Screener
Capricor Therapeutics CAPR Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
| Line item | March 31, 2026 / (unaudited) | December 31, 2025 | December 31, 2025 |
|---|---|---|---|
| COMMITMENTS AND CONTINGENCIES (NOTE 15) | |||
| STOCKHOLDERS’ EQUITY | |||
| Preferred stock, $0.001 par value, 5,000,000 shares authorized, none issued and outstanding | — | — | |
| Common stock, $0.001 par value, 100,000,000 shares authorized, 57,664,673 and 57,370,909 shares issued and outstanding, respectively | 57,665 | 57,371 | |
| Additional paid-in capital | 617,718,525 | 610,330,105 | |
| Accumulated other comprehensive income | (253,727) | 283,154 | |
| Accumulated deficit | (338,819,830) | (304,878,485) | |
| TOTAL STOCKHOLDERS’ EQUITY | 278,702,633 | 305,792,145 |
Item 1. Financial Statements.
FAQ
- What is Capricor Therapeutics's common stock?
- Capricor Therapeutics (CAPR) reported common stock of $57.67K in Q1 2026.
- How has Capricor Therapeutics's common stock changed year-over-year?
- Capricor Therapeutics's common stock increased by 26.2% year-over-year, from $45.68K to $57.67K.
- What is the long-term trend for Capricor Therapeutics's common stock?
- Over 5 years (2020 to 2025), Capricor Therapeutics's common stock has grown at a 22.8% compound annual growth rate (CAGR), from $20.58K to $57.37K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Capricor Therapeutics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude